Skip to main content
THAR
NASDAQ Life Sciences

Canton Strategic Holdings, Inc. Rebrands, Changes Ticker to CNTN for Digital Asset Strategy

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
7
Price
$4.826
Mkt Cap
$187.371M
52W Low
0
52W High
0
Market data snapshot near publication time

summarizeSummary

Tharimmune, Inc. has officially rebranded to Canton Strategic Holdings, Inc. and changed its Nasdaq ticker symbol to CNTN, aligning its corporate identity with its new digital asset treasury strategy.


check_boxKey Events

  • Corporate Name Change

    The company officially changed its corporate name from Tharimmune, Inc. to Canton Strategic Holdings, Inc.

  • Ticker Symbol Change

    The Nasdaq ticker symbol for the company's common stock changed from 'THAR' to 'CNTN', effective February 18, 2026.

  • Strategic Alignment

    The rebrand is explicitly stated to align with the company's digital asset treasury strategy, focusing on the Canton Network and Canton Coin, a strategy previously detailed in recent filings.

  • Bylaws Amended

    The company's bylaws were amended and restated to reflect the new corporate name and the current size of the Board of Directors.


auto_awesomeAnalysis

This 8-K filing formalizes the corporate name change from Tharimmune, Inc. to Canton Strategic Holdings, Inc., and the ticker symbol change from THAR to CNTN, effective February 18, 2026. This rebrand aligns the company's identity with its recently announced digital asset treasury strategy, which includes leveraging Canton Coin and operating as a Super Validator on the Canton Network. This follows a series of significant strategic moves, including the approval as a Super Validator on January 26, 2026, and the closing of a $55 million registered offering on January 22, 2026, to fund this new direction. The name change reinforces the company's commitment to its new focus on institutional blockchain adoption and the digitization of financial markets.

At the time of this filing, THAR was trading at $4.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $187.4M. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed THAR - Latest Insights

THAR
Feb 18, 2026, 8:45 AM EST
Filing Type: 8-K
Importance Score:
7
THAR
Feb 06, 2026, 8:20 AM EST
Filing Type: 8-K
Importance Score:
7
THAR
Feb 02, 2026, 8:20 AM EST
Filing Type: 8-K
Importance Score:
7
THAR
Jan 26, 2026, 9:51 PM EST
Filing Type: DEFA14A
Importance Score:
7
THAR
Jan 26, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
THAR
Jan 22, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
9
THAR
Jan 20, 2026, 10:52 AM EST
Filing Type: 8-K
Importance Score:
9
THAR
Jan 20, 2026, 9:05 AM EST
Filing Type: 424B5
Importance Score:
9
THAR
Jan 16, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
9
THAR
Jan 15, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8